Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
9.27
+0.59 (6.77%)
Oct 8, 2025, 4:00 PM EDT - Market closed
Addex Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Addex Therapeutics.
Price Target: $ (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Addex Therapeutics.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +223.70% | Oct 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +223.70% | Aug 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $30 | Hold → Strong Buy | Upgrades | $30 | +223.70% | Jul 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 23, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $420 → $300 | Strong Buy | Maintains | $420 → $300 | +3,137.05% | May 31, 2022 |
Financial Forecast
Revenue This Year
765.00K
from 410.04K
Increased by 86.57%
Revenue Next Year
765.00K
from 765.00K
EPS This Year
-0.07
from 0.07
EPS Next Year
-0.04
from -0.07
Financial currency is CHF. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.6M | 1.6M | |
| Avg | 765,000 | 765,000 | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 284.1% | 105.9% | |
| Avg | 86.6% | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.07 | -0.04 |
| Avg | -0.07 | -0.04 |
| Low | -0.07 | -0.04 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.